Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2023

Every FDA drug recall initiated in 2023, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,122 recalls, newest first.

Class II · Moderate risk

EPINEPHrine added to dextrose 5%

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-6030-1 D-0701-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0432-1 D-0700-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0430-1 D-0699-2023
Class II · Moderate risk

Neonatal PN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0429-1 D-0698-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0428-1 D-0697-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0427-1 D-0696-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0425-1 D-0695-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0423-1 D-0694-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0422-1 D-0693-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0421-1 D-0692-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0420-1 D-0691-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0419-1 D-0690-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0418-1 D-0689-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0416-1 D-0688-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0413-1 D-0687-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0408-1 D-0686-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0407-1 D-0685-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0406-1 D-0684-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0405-1 D-0683-2023

Recalls by year